D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Markel Group
MKL
$25B
| $8.62M | 0.01% |
9,292
+5,530
| +147% | +$6.32M |
|
|
DOO
1027
Bombardier Recreational Products
DOO
$4.43B
| $8.62M | 0.01% |
527,585
+456,085
| +638% | +$18.7M |
|
1028
PUT
Elevance Health
ELV
$81.9B
| $8.61M | 0.01% |
37,900
+7,300
| +24% | +$1.99M |
|
1029
PUT
Estee Lauder
EL
$29B
| $8.59M | 0.01% |
53,900
-17,700
| -25% | -$3.42M |
|
1030
Teck Resources
TECK
$29.5B
| $8.56M | 0.01% |
1,128,392
+159,858
| +17% | +$1.91M |
|
1031
Pebblebrook Hotel Trust
PEB
$2.16B
| $8.56M | 0.01% |
786,151
+619,875
| +373% | +$12.6M |
|
|
IRBT
1032
CALL
DELISTED
iRobot
IRBT
| $8.53M | 0.01% |
208,500
-60,000
| -22% | -$2.88M |
|
1033
EastGroup Properties
EGP
$11.5B
| $8.53M | 0.01% |
+81,602
| New | +$10.3M |
|
1034
CALL
Universal Display
OLED
$3.71B
| $8.51M | 0.01% |
64,600
-69,600
| -52% | -$12M |
|
1035
Steris
STE
$20.9B
| $8.51M | 0.01% |
60,780
-126,186
| -67% | -$18.9M |
|
|
VMW
1036
PUT
DELISTED
VMware, Inc
VMW
| $8.5M | 0.01% |
70,200
+12,100
| +21% | +$1.66M |
|
1037
PUT
W.W. Grainger
GWW
$65.3B
| $8.5M | 0.01% |
34,200
+7,300
| +27% | +$2.16M |
|
1038
International Bancshares
IBOC
$4.77B
| $8.49M | 0.01% |
315,967
+119,322
| +61% | +$4.27M |
|
|
BPMC
1039
DELISTED
Blueprint Medicines
BPMC
| $8.47M | 0.01% |
144,781
-13,489
| -9% | -$868K |
|
1040
Armstrong World Industries
AWI
$6.86B
| $8.45M | 0.01% |
106,341
-143,773
| -57% | -$13.9M |
|
|
CONE
1041
DELISTED
CyrusOne Inc Common Stock
CONE
| $8.43M | 0.01% |
136,511
-251,641
| -65% | -$15.4M |
|
1042
Autoliv
ALV
$8.6B
| $8.4M | 0.01% |
182,574
+173,591
| +1,932% | +$11.9M |
|
|
1043
CALL
Estee Lauder
EL
$29B
| $8.4M | 0.01% |
52,700
-6,700
| -11% | -$1.29M |
|
|
BFYT
1044
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $8.39M | 0.01% |
374,893
+301,997
| +414% | +$7.17M |
|
1045
PUT
Dow Inc
DOW
$21.6B
| $8.39M | 0.01% |
287,000
+239,182
| +500% | +$10.2M |
|
1046
PUT
LendingTree
TREE
$544M
| $8.38M | 0.01% |
45,700
+13,200
| +41% | +$3.73M |
|
1047
Allegion
ALLE
$13B
| $8.37M | 0.01% |
90,989
+18,920
| +26% | +$2.26M |
|
|
COUP
1048
PUT
DELISTED
Coupa Software Incorporated
COUP
| $8.37M | 0.01% |
59,900
-13,700
| -19% | -$2.12M |
|
|
AXE
1049
DELISTED
Anixter International Inc
AXE
| $8.36M | 0.01% |
95,108
-24,380
| -20% | -$2.31M |
|
1050
CALL
Edwards Lifesciences
EW
$47.6B
| $8.36M | 0.01% |
132,900
-17,700
| -12% | -$1.28M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.